bioMrieux's 2016 Financial Results - Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: => 2,103 million in sales=> Up 7.1% as reported - Contributive operating income before non-recurring items: => 298 million, or 14.2% of sales=> Up 14.5% - Earnings per share up 62% year-on-year "... buoyed by the commitment of Alexandre Mrieux and backed by the expertise and dedication of our teams, we will continue to invest in our future in 2017 to best serve our customers, patients and public health mission." said Jean-Luc Belingard, bioMrieux Chairman. More: http://www.biomerieux.com/en/biomerieux-2016-financial-results-0
Mar 1 at 7:57 AM
bioMrieuxs VIDAS BRAHMS PCT becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis. "... This FDA clearance illustrates our capacity to provide clinicians with high medical value tests to help them make important treatment decisions. The goal is to achieve better outcomes for patients and to ensure that each of them receives the appropriate treatment, said Mark Miller, Corporate VP, Chief Medical Officer at bioMrieux. More: http://www.biomerieux.com/en/biomerieuxs-vidasr-brahms-pcttm-becomes-first-fda-cleared-procalcitonin-assay-aid-antibiotic
Jan 13 at 7:23 PM
Just in.... bioMrieux Americas team getting excited about serving our customers and public health in 2017! Go team, Go!
Nov 26 at 5:53 AM
Mar 1, 8:24 AM
bioMrieux's 2016 Financial Results - Remarkable growth in sales in 2016, up 9.6% at constant exchange rates and scope of consolidation: => 2,103 million in sales=> Up 7.1% as reported - Contributive operating income before non-recurring items: => 298 million, or 14.2% of sales=> Up 14.5% - Earnings per share up 62% year-on-year "... buoyed by the commitment of Alexandre Mrieux and backed by the expertise and dedication of our teams, we will continue to invest in our future in 2017 to best serve our customers, patients and public health mission." said Jean-Luc Belingard, bioMrieux Chairman. More: http://www.biomerieux.com/en/biomerieux-2016-financial-results-0
Mar 1, 7:57 AM
bioMrieuxs VIDAS BRAHMS PCT becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis. "... This FDA clearance illustrates our capacity to provide clinicians with high medical value tests to help them make important treatment decisions. The goal is to achieve better outcomes for patients and to ensure that each of them receives the appropriate treatment, said Mark Miller, Corporate VP, Chief Medical Officer at bioMrieux. More: http://www.biomerieux.com/en/biomerieuxs-vidasr-brahms-pcttm-becomes-first-fda-cleared-procalcitonin-assay-aid-antibiotic
Jan 13, 7:23 PM
Just in.... bioMrieux Americas team getting excited about serving our customers and public health in 2017! Go team, Go!
Designs, develops and communicates the purchasing commodity strategies under their responsibility and drives the implementation through bioMérieux' organization (global responsibility). Masters assigned commodity in terms of cost models, benchmarks, market trends, product technical roadmaps, key supplier awareness, and target costing.
The Clinical Education Manager will work to increase awareness, acceptance, and utilization of targeted immunoassays in selected accounts through education and development of key opinion leaders.
Work closely with Regional Sales and Service Management to demonstrate service value to customers and optimize total service profitability; establish service sales and marketing activities to promote service products and capabilities, grow the service business, and increase service revenue.
Participate in the identification, selection, validation and administration of the cybersecurity tools (e.g. scanners, static analysis, etc) and provide guidelines or procedures on their use.
Evaluating current institutional treatment guidelines, recommendations on improving these through the use of biomerieux products and providing education on the clinical utility of bioMerieux's Emergency Medicine diagnostic product line to current and future customers.
Strong foundation of in development of algorithms to translate instrumentation/sensor data to functional results; experience with image processing algorithm design.
Responds expediently to all requests for customer instrument service via communications with service office; ensures that all instrument service requests are fulfilled within area of geographic responsibility.
Maintains MRP views on Distribution Centers in the Information System, and ensures data quality (min/max/Safety stock, lead times, frozen horizons, quotas, etc.).
Provides the required leadership and support to ensure improvement with Corporate HSE Management System and applicable requirements, while minimizing the risk of potential adverse HSE events across the region.
Develop and maintain project schedules - support multiple ongoing projects; work with internal and external resources to achieve goals; resolve technical problems on the production floor utilizing Engineering analysis.
The Raw Material Category Manager will collaborate with the global purchasing team including their Manager and Director to define and implement bioMérieux' global purchasing strategies for assigned commodities (Substrates, Filtration, Peptones, Products from animal origins, Peptones�).
Conducts and manages Supplier Panel Business Risk analysis; defines Supplier Panel and drives its implementation (including approval and disapproval of suppliers, jointly with the contributing functions).